Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
出版年份 2022 全文链接
标题
Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
作者
关键词
-
出版物
Microorganisms
Volume 11, Issue 1, Pages 30
出版商
MDPI AG
发表日期
2022-12-22
DOI
10.3390/microorganisms11010030
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- SARS-CoV-2 Variants, Vaccines, and Host Immunity
- (2022) Priyal Mistry et al. Frontiers in Immunology
- From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
- (2022) Vasileios Papanikolaou et al. GENE
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
- (2022) Matthew McCallum et al. SCIENCE
- Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- (2022) Yang Liu et al. Cell Reports
- Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
- (2022) Daichi Yamasoba et al. LANCET INFECTIOUS DISEASES
- Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
- (2022) Li Wang et al. Nature Communications
- Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
- (2022) Fanchong Jian et al. LANCET INFECTIOUS DISEASES
- Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
- (2022) Zhennan Zhao et al. Nature Communications
- The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
- (2022) Maria Jose Lista et al. JOURNAL OF VIROLOGY
- Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
- (2021) Kathy Leung et al. Eurosurveillance
- SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis
- (2021) Armin Bayati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
- (2021) Kevin R. McCarthy et al. SCIENCE
- A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
- (2021) Yunkai Zhu et al. Nature Communications
- SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
- (2021) Seiya Ozono et al. Nature Communications
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data
- (2021) Abbas Khan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
- (2021) Simone Di Giacomo et al. JOURNAL OF MEDICAL VIROLOGY
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Structural impact on SARS-CoV-2 spike protein by D614G substitution
- (2021) Jun Zhang et al. SCIENCE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
- (2021) Yeong Jun Kim et al. Viruses-Basel
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
- (2021) Darren P. Martin et al. CELL
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
- (2021) Chihiro Motozono et al. Cell Host & Microbe
- Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity
- (2021) Vipul Kumar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
- (2021) Bahaa Jawad et al. Journal of Chemical Information and Modeling
- Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
- (2021) Meng Yuan et al. SCIENCE
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- The virological impacts of SARS-CoV-2 D614G mutation
- (2021) Chenxi Wang et al. Journal of Molecular Cell Biology
- Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
- (2021) Bo Meng et al. Cell Reports
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
- (2021) Sarah Cherian et al. Microorganisms
- Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion
- (2021) Prabin Baral et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- (2021) Akatsuki Saito et al. NATURE
- Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
- (2021) Bailey Lubinski et al. iScience
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
- (2020) Kazuma Kiyotani et al. JOURNAL OF HUMAN GENETICS
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein‐enhanced fitness in SARS‐COV ‐2
- (2020) I. Olaposi Omotuyi et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
- (2020) Xiaoyi Fan et al. Nature Communications
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2020) Andrew Rambaut et al. Nature Microbiology
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
- (2020) Leonid Yurkovetskiy et al. CELL
- Molecular Architecture of the SARS-CoV-2 Virus
- (2020) Hangping Yao et al. CELL
- The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2
- (2020) Natacha S. Ogando et al. JOURNAL OF VIROLOGY
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
- (2020) Drew Weissman et al. Cell Host & Microbe
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
- (2020) Sophie M.-C. Gobeil et al. Cell Reports
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
- (2019) Alexandra C. Walls et al. CELL
- Nextstrain: real-time tracking of pathogen evolution
- (2018) James Hadfield et al. BIOINFORMATICS
- Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
- (2017) Alexandra C. Walls et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subgenomic messenger RNAs: Mastering regulation of (+)-strand RNA virus life cycle
- (2011) Joanna Sztuba-Solińska et al. VIROLOGY
- Coronavirus Genomics and Bioinformatics Analysis
- (2010) Patrick C. Y. Woo et al. Viruses-Basel
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started